BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6127161)

  • 1. [Effect of metipranolol and other blockaders of beta-receptors in experimental animals and man].
    Mayer O; Trcka V
    Cas Lek Cesk; 1982 Sep; 121(34-35):1083-6. PubMed ID: 6127161
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in cardiac output, induced by metipranolol and other beta-blockers, in dogs.
    Helfert I; Vanĕcek M; Trcka V
    Acta Univ Carol Med (Praha); 1980; 26(7-8):345-9. PubMed ID: 6126107
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of metipranolol and other beta-blockers on the heart in reserpinized rats.
    Vanĕcek M; Trcka V; Helfert I
    Acta Univ Carol Med (Praha); 1980; 26(7-8):339-43. PubMed ID: 6126106
    [No Abstract]   [Full Text] [Related]  

  • 4. Beta-blocking drug metipranolol: plasma levels and pharmacodynamic action in man.
    Mayer O; Cepelák V; Vitous J; Potmĕsil J
    Int J Clin Pharmacol Ther Toxicol; 1980 Mar; 18(3):113-9. PubMed ID: 6103879
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparative study of the effects of metipranolol, propranolol, alprenolol, oxprenolol, pindolol and practolol on the circulation in experimental animals.
    Trcka V; Vanĕcek M; Helfert I; Mácová S
    Acta Univ Carol Med (Praha); 1980; 26(5-6):239-58. PubMed ID: 6126104
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of the new beta-adrenolytic compound propyl-3-acetyl-4-[(2-hydroxy-3-isopropylamino) propoxy]carbanylate hydrochloride on isolated heart muscle.
    Knezl V; Magna D; Sotníková R; Drímal J
    Arzneimittelforschung; 1994 Jan; 44(1):7-12. PubMed ID: 7907875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological demonstration of beta 1 selectivity of beta-receptor blockaders].
    Lundgren B; Carlsson E; Ablad B
    Med Welt; 1978 Sep; 29(39):1531. PubMed ID: 29208
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of beta-blocking agent Metipranolol on metabolic variables in patients with ischemic heart disease, hyperkinetic syndrome, hyperthyreosis and in healthy subjects.
    Ceremuzynski L; Zaleska T; Nauman J; Nauman A; Zalewski A
    Int J Clin Pharmacol Biopharm; 1979 Jun; 17(6):244-9. PubMed ID: 38215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanism of action of the new beta-adrenolytic drug VUL 111 upon the cardiovascular system. 1. Beta-adrenolytic activity on peroral administration and ways of metabolic degradation (author's transl)].
    Drimal J; Strízová K; Borovicová F; Gibala P; Stefek M; Kovácik V
    Bratisl Lek Listy; 1978 Jul; 70(1):11-28. PubMed ID: 28818
    [No Abstract]   [Full Text] [Related]  

  • 10. [Local propranolol blocking of the beta-adrenergic receptors of the sinoatrial node during intravenous infusion of isoproterenol. Experimental research].
    Mezzacapo B; Massaria E; Di Fabio D
    Minerva Cardioangiol; 1969 Dec; 17(12):1074-9. PubMed ID: 4392066
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of beta adrenergic blocking agents on erythropoiesis in rats.
    Zivný J; Ostádal B; Neuwirt J; Procházka J; Pelouch V
    J Pharmacol Exp Ther; 1983 Jul; 226(1):222-5. PubMed ID: 6134822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experiments in animals on the pharmacological effects of metipranolol in comparison with propranolol and pindolol.
    Bartsch W; Sponer G; Dietmann K
    Arzneimittelforschung; 1977; 27(12):2319-22. PubMed ID: 23798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison in healthy volunteers of the systemic beta adrenergic receptor blockade by beta blockader eye drops].
    de Dieuleveult C; Queinnec MC; Pinaud M; Souron R
    Ann Fr Anesth Reanim; 1989; 8(1):46-50. PubMed ID: 2565697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiovascular effects of timolol, carteolol, metipranolol, betaxolol collyres in the aged patient].
    Le Jeunne C; Bringer L; Mondjee-Tahura Z; Munera Y; Hugues FC
    Therapie; 1988; 43(2):89-92. PubMed ID: 2900562
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of adrenergic beta receptor blockers on phospholipid metabolism in mast cells].
    Pecivová J; Drábiková K; Nosál' R
    Bratisl Lek Listy; 1990 May; 91(5):363-8. PubMed ID: 1974476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metipranolol and propranolol: no CNS effects of a single oral dose.
    Levander S; Gillner A
    Psychopharmacology (Berl); 1982; 76(4):359-66. PubMed ID: 6126894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Beta adrenergic blockers and their effect on erythropoiesis (author's transl)].
    Zivný J; Ostádal B; Neuwirt J; Procházka J; Pelouch V
    Cas Lek Cesk; 1982 Mar; 121(11):327-31. PubMed ID: 6121627
    [No Abstract]   [Full Text] [Related]  

  • 18. [Stereospecificity of beta-blocker effects on the glaucomatous eye].
    Krieglstein GK; Schrems W
    Fortschr Ophthalmol; 1984; 81(2):127-9. PubMed ID: 6145665
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of a new beta-blocking drug, DL 071-IT, on the myocardial contractile state in the waking dog; a comparison with 9 known beta blockaders].
    Marchetti G; Di Francesco GF; Baldoli E
    Boll Soc Ital Cardiol; 1979; 24(9):1039-43. PubMed ID: 45253
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of propranolol and metipranolol on systolic time intervals in health volunteers].
    Smíd J; Cepelák V; Mayer O
    Vnitr Lek; 1981 Jul; 27(7):683-90. PubMed ID: 6117982
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.